Project Updates and Milestones news (page 41)

• 

  10 March 2026

  Aramco Reports Q4 and FY 2025 Financial Results

  Strong 2025 financials: $104.7B net income, $85.4B free cash flow, 3.8% gearing. $85.5B shareholder distributions, AI-driven $5.3B value, 70% localization, gas expansion on track.
• 

  9 March 2026

  Trafigura signs 10-year take-or-pay for 80,000 t battery-grade lithium carbonate from Smackover Lithium

  Secures 8,000 tpa (80,000 t total) of battery-grade lithium carbonate from a US brine project using direct lithium extraction; FID expected 2026, first production targeted 2028.
• 

  9 March 2026

  MOL Group and JANAF Begin 10-Month Adria Pipeline Capacity Tests

  The Adria pipeline undergoes 10-month tests to assess transport performance, logistics, and capacity, involving international experts. Results aim to resolve capacity debates by 2027.
• 

  9 March 2026

  Infineum Opens New Blending Facility in India

  The new facility in Patalganga enhances supply reliability, supports local manufacturing, and aligns with India's growth and sustainability goals.
• 

  8 March 2026

  Genentech Updates on Phase III persevERA Study in ER-Positive Breast Cancer

  persevERA study showed no significant progression-free survival improvement, but giredestrant was well tolerated. Further studies planned with CDK4/6 inhibitors.
• 

  6 March 2026

  Petrobras 2025 Net Profit Hits R$ 110 Billion

  Despite a 14% Brent price drop, increased oil and gas production drove strong financial results, with R$ 200 billion in operational cash flow and significant investments in E&P projects.

• 

  6 March 2026

  TotalEnergies Releases Independent Review of Tilenga Project Land Acquisition in Uganda

  The assessment confirms compliance with land acquisition standards. An action plan addresses livelihood restoration, support for vulnerable households, grievance management, and gender considerations.
• 

  6 March 2026

  Gasunie 2025 Report: Advancing Resilient and Sustainable Energy Systems

  Invested €1.2B in energy security and transition. Hydrogen, CO2 projects near completion. Net profit rose to €85M. Gas transport up, especially to power stations.
• 

  5 March 2026

  Johnson & Johnson's TECVAYLI and DARZALEX FASPRO Approved by FDA for Relapsed Multiple Myeloma

  FDA approves TECVAYLI plus DARZALEX FASPRO for relapsed multiple myeloma, offering a new treatment option as early as second line with improved safety and efficacy.
• 

  5 March 2026

  Genentech Reports Positive Phase II Results for Petrelintide in Obesity Treatment

  Petrelintide shows significant weight loss and good tolerability in Phase II trial, supporting further development for chronic weight management.
• 

  5 March 2026

  RWE Adds 2 GW to U.S. Energy Capacity

  RWE completed 15 projects in 2025, adding solar, wind, and battery storage across seven U.S. states, creating 3,500 jobs and investing over $500 million in local communities.
• 

  4 March 2026

  SABIC turnaround at Chemelot

  Six-week maintenance of naphtha cracker Olefins 4 with inspections, upgrades and scheduled flaring; hundreds of extra workers will increase local traffic.
• 

  4 March 2026

  thyssenkrupp Uhde Installs EnviNOx® for Emission Cuts at CSBP Nitric Acid Plants

  EnviNOx® tech cuts N₂O emissions by 98% at CSBP's NAAN3 plant, aiding WesCEF's 2030 emission goals and supporting decarbonization in agriculture and mining.
• 

  4 March 2026

  Topsoe's 2025 Financial Results Meet Expectations in Tough Market

  Revenue reached DKK 8,197 million. EBIT margin at 8.9%. SAF projects in China. New CEO from March 2026. 2026 outlook: revenue DKK 7,600-8,400 million, EBIT margin 0.0-5.0%.
• 

  4 March 2026

  thyssenkrupp Uhde's EnviNOx® Cuts Nitrous Oxide Emissions at CSBP

  EnviNOx® tech reduces N₂O emissions by 98% at CSBP's nitric acid plants, aiding WesCEF's 2030 emissions goals and supporting decarbonization in agriculture and mining.
• 

  4 March 2026

  NEXTCHEM Secures €485M Contract for Hydrogen, Ammonia, Urea, and Methanol Technologies in West Africa

  The project includes hydrogen, ammonia, and urea units across three sites. Engineering has begun, with €10M recognized pre-FID.
• 

  4 March 2026

  Sinopec Backs New National Greenhouse Gas Emission Database

  The updated database includes methane emission factors for onshore facilities, aiding accurate greenhouse gas calculations and supporting emission reduction efforts in the oil and gas sector.
• 

  3 March 2026

  Johnson & Johnson's Nipocalimab Gets FDA Fast Track for Lupus Treatment

  Nipocalimab, an investigational therapy, aims to address unmet needs in lupus by reducing harmful IgG while preserving immune function, following positive Phase 2b results.
• 

  3 March 2026

  Equinor Investigates Deepsea Bollsta Well Control Incident

  A gas leak on Deepsea Bollsta was contained in 30 minutes. Safety systems worked, preventing escalation. Measures are in place to avoid recurrence.
• 

  3 March 2026

  RIFT Secures €114M to Scale Iron Fuel Technology

  €113.8M funding will develop a commercial iron fuel facility, aiming to decarbonize industrial heat and avoid over 1M tonnes of CO₂ emissions. Operational by 2029.
• 

  2 March 2026

  Carbon Direct and C2X advance Beaver Lake forestry-residue-to-biomethanol project

  Transforms Louisiana forestry and sawmill residues into biomethanol and durable CO₂ storage; FEED nearing completion, FID targeted in 2026 with production from 2029.
• 

  2 March 2026

  Takeda's Rusfertide Receives FDA Priority Review

  Rusfertide shows promise in controlling hematocrit and reducing symptoms in polycythemia vera, with FDA review based on positive Phase 3 and long-term study data.
• 

  2 March 2026

  Equinor's Rapid Development Plan for Snorre Oil Discovery

  New oil discovery in Snorre area to be quickly developed using existing infrastructure, reducing costs and environmental impact, while supporting European energy security.
• 

  2 March 2026

  thyssenkrupp Uhde to Study Biomass-to-Methanol Integration for Nova Sustainable Fuels in Canada

  The study will assess the integration of gasification and methanol synthesis to produce 450,000 metric tons of bio-methanol annually, aiding decarbonization in transportation and shipping.
• 

  2 March 2026

  Galp 4Q & FY25 Financial Results

  Strong 2025 performance with €2.2bn cash generation, 4% DPS increase, and €250m buyback. Key growth in Brazil, Namibia, and Sines. Net debt at €1.3bn, FCF at €81m.
• 

  1 March 2026

  Genentech's Fenebrutinib Shows Promise as BTK Inhibitor for MS in Phase III Study

  Fenebrutinib reduced relapses by 51% in RMS, consistent with prior studies. Data will be submitted to regulators. Safety profile comparable to teriflunomide; further analysis on fatalities ongoing.
• 

  28 February 2026

  Merck and Eisai: WELIREG and LENVIMA Reduce Disease Progression Risk by 30% in Advanced RCC Trial

  Phase 3 trial shows WELIREG plus LENVIMA improves progression-free survival in advanced RCC, with FDA reviewing new drug applications.
• 

  27 February 2026

  FDA Approves Novo Nordisk's Sogroya for New Pediatric Uses

  Sogroya, a once-weekly growth hormone, is now approved for children with ISS, SGA, or NS, offering an alternative to daily injections and expanding treatment options.
• 

  27 February 2026

  Merck's KEYTRUDA and Padcev Cut Event-Free Survival Risk by 47% and Mortality by 35% in Cisplatin-Eligible Bladder Cancer Patients

  KEYTRUDA plus Padcev improves survival and reduces recurrence in muscle-invasive bladder cancer, showing potential as a new standard for cisplatin-eligible patients.
• 

  27 February 2026

  Lilly's Olumiant Gains CHMP Nod for Adolescent Alopecia Areata in EU

  CHMP backs Olumiant for severe alopecia areata in adolescents, based on Phase 3 study showing 42% achieved 80% scalp hair coverage at 36 weeks. Awaiting European Commission decision.